I think that there would be benefits of billions of dollars from outlawing these reverse payment settlements.
Pay-for-delay settlements are the most egregious form of antitrust violation in my mind.
The CBO, as we know, expects this legislation would accelerate the availability of generic drugs and save $4.7 billion o...
You have an FTC which probably does not have the resources to match yours and the pharmaceutical industry.
Many more cases settle without pay-for-delay than with pay-for-delay.
What incentive do they have not to do it?
It seems to me the evidence suggests that just putting it back to rule of reason should have--should do the trick based ...
It is the pay-for-delay settlement that we have concerns about, Senator Grassley and I, Senator Vitter and Senator Frank...
it is entirely proper to put the burden on the drug companies to demonstrate that actually these have a pro-competitive,...
So that is why we were coming up, Senator Grassley and I, with a way to sort of even the playing field.
I think the door was opened, and we have come up with what I consider a reasonable compromise in this bill.